Vicapsys Life Sciences Inc (VICP)
OTHER OTC:VICP
US Market
Holding VICP?
Track your performance easily

Vicapsys Life Sciences (VICP) Stock Price & Analysis

0 Followers

VICP Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%0.00%0.23%99.77%
0.00%
Insiders
0.00%
Mutual Funds
0.23% Other Institutional Investors
99.77% Public Companies and
Individual Investors

VICP FAQ

What was Vicapsys Life Sciences Inc’s price range in the past 12 months?
Vicapsys Life Sciences Inc lowest stock price was $0.42 and its highest was $14.00 in the past 12 months.
    What is Vicapsys Life Sciences Inc’s market cap?
    Currently, no data Available
    When is Vicapsys Life Sciences Inc’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Vicapsys Life Sciences Inc’s earnings last quarter?
    Currently, no data Available
    Is Vicapsys Life Sciences Inc overvalued?
    According to Wall Street analysts Vicapsys Life Sciences Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Vicapsys Life Sciences Inc pay dividends?
      Vicapsys Life Sciences Inc does not currently pay dividends.
      What is Vicapsys Life Sciences Inc’s EPS estimate?
      Vicapsys Life Sciences Inc’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Vicapsys Life Sciences Inc have?
      Vicapsys Life Sciences Inc has 32,071,300 shares outstanding.
        What happened to Vicapsys Life Sciences Inc’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Vicapsys Life Sciences Inc?
        Currently, no hedge funds are holding shares in VICP
        ---

        Vicapsys Life Sciences Stock Smart Score

        Company Description

        Vicapsys Life Sciences Inc

        Vicapsys Life Sciences, Inc. is a development stage biotechnology company, which advances proprietary localized immune modulator. Its initial pipeline products include type 1 diabetes, post-surgical abdominal adhesion formation, and post-trauma keloid formation. The company was founded on December 26, 1996 and is headquartered in Cumming, GA.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Arca Biopharma
        Bioxcel Therapeutics
        G1 Therapeutics
        Novavax
        Popular Stocks
        ---
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis